Previsioni di mercato dell\'outsourcing degli affari normativi nel settore sanitario per l\'Asia Pacifico fino al 2028 - Impatto del COVID-19 e analisi regionale per tipo di servizio (sviluppo di strategie scientifiche e normative, scrittura medica e scientifica, eCTD e invii elettronici, servizi di gestione dei dati, servizi di gestione del ciclo di vita, farmacovigilanza, Servizi di produzione e controlli chimici (CMC), etichettatura normativa e servizi di grafica normativa) e utente finale (aziende farmaceutiche, aziende di biotecnologia e aziende di dispositivi medici)
Introduzione al mercato
L\'Asia Pacifico è composta da cinque paesi principali: Cina, Giappone, India, Australia e Corea del Sud. Il mercato viene valutato anche per il resto dei paesi dell\'Asia Pacifico. Il mercato è guidato da fattori quali costi relativamente più bassi per l’outsourcing, forza lavoro qualificata con competenze tecniche ed espansione delle aziende sanitarie in paesi come India e Cina. Inoltre, si prevede che un numero crescente di studi clinici e un numero crescente di aziende che tentano di entrare nei mercati delle economie emergenti come India, Sud-est asiatico e Cina contribuiranno alla crescita del mercato per l’outsourcing degli affari regolatori sanitari durante il periodo di previsione. Il mercato farmaceutico giapponese sta crescendo in modo esponenziale. Per rispondere alle esigenze del crescente invecchiamento della popolazione giapponese, il governo si sta concentrando sull\'allentamento delle politiche di regolamentazione e quindi sull\'accelerazione dello sviluppo e dell\'approvazione di nuovi farmaci sul mercato. Si prevede che ciò attirerà le aziende farmaceutiche globali già esistenti e i nuovi concorrenti a stabilire il loro mercato in Giappone. Si prevede che ciò aumenterà la domanda di vari servizi di outsourcing normativo che richiedono dallo sviluppo del tipo di servizio alla fase di commercializzazione del tipo di servizio. Per ridurre i costi e semplificare la tempistica del tipo di servizio, le aziende si stanno concentrando principalmente sull’esternalizzazione delle attività di regolamentazione e farmacovigilanza alle industrie. Si prevede che ciò stimolerà la crescita del mercato dell’outsourcing degli affari regolatori sanitari in questo paese. I progressi nelle terapie specialistiche, nei farmaci orfani e nei farmaci personalizzati rappresentano il fattore principale che guida la crescita del mercato dell\'outsourcing degli affari regolatori sanitari nell\'area APAC.
Con un mercato di fornitura favorevole, la forte presenza delle CRO globali e regionali con competenze locali: le aziende farmaceutiche percepiscono l\'Asia-Pacifico come un mercato attraente per la conduzione di studi clinici. Tuttavia, la pandemia di COVID-19 ha portato sfide senza precedenti in tutto il mondo. L’impatto di COVID-19 sugli affari clinici e normativi, sulla produzione e sulle catene di fornitura e sul coinvolgimento delle parti interessate ha rallentato il ritmo del settore farmaceutico in continua crescita. L’Australia è stata apprezzata a livello globale per le sue misure di gestione della diffusione del COVID-19 con rigorosi sistemi di quarantena e tracciamento avanzato dei contatti; tuttavia, la partecipazione dei pazienti/volontari agli studi clinici è diminuita in alcuni centri poiché i partecipanti non erano disposti a frequentare cliniche o ospedali per paura di un\'infezione. Pertanto, la situazione pandemica ha comportato l’interruzione degli studi clinici, ritardi nell’approvazione dei prodotti e interruzioni nelle catene di approvvigionamento. La pandemia ha costretto le aziende farmaceutiche e le agenzie di regolamentazione ad adottare strategie innovative per mitigare le sfide osservate in vari ambiti funzionali. L\'impatto del COVID-19 ha comportato un ritardo nell\'ispezione in loco a causa delle barre di spostamento e un ritardo nell\'approvazione di diversi prodotti. Ciò ha portato all’esternalizzazione di circa il 65% delle attività farmaceutiche alle CRO e si prevede che tale cifra raggiungerà il 75% in futuro. Insieme a ciò, la domanda di prodotti farmaceutici innovativi ha messo sotto pressione le aziende farmaceutiche affinché aumentassero la spesa in ricerca e sviluppo per fornire i nuovi prodotti, mantenendo inalterati i costi operativi. Queste condizioni hanno anche innescato investimenti in piattaforme digitali, consentendo ai medici di monitorare i pazienti da remoto in modo efficiente. Tutti questi fattori avranno un impatto sulle attività di outsourcing degli affari normativi nel settore sanitario nella regione Asia-Pacifico.
Panoramica e dinamiche del mercato
Si prevede che il mercato dell\'outsourcing degli affari regolatori sanitari nell\'APAC crescerà da 1.203,97 milioni di dollari nel 2021 a 2.586,87 milioni di dollari entro il 2028; si stima che crescerà a un CAGR dell\'11,5% dal 2021 al 2028. Il settore degli affari regolatori sanitari è altamente frammentato con diverse centinaia di fornitori di servizi limitati di piccole e medie dimensioni e un piccolo numero di grandi CRO multinazionali a servizio completo . Le piccole CRO devono affrontare alcune barriere per entrare nel mercato dell\'outsourcing degli affari regolatori sanitari, mentre le CRO a servizio completo con presenza regionale devono costruire l\'infrastruttura necessaria con la capacità di gestire simultaneamente più servizi normativi complessi in numerosi paesi; questi ultimi devono anche costruire le relazioni necessarie con partner strategici, sviluppando competenze terapeutiche e di competenza pertinenti per soddisfare le esigenze dei loro clienti. Il consolidamento nel settore degli affari normativi è una tendenza emergente che aiuta i principali attori a rafforzare la propria offerta di servizi e ad acquisire la quota maggiore del mercato. Tuttavia, ciò ha portato alla generazione di una manciata di CRO più grandi con un\'ampia portata, ampie competenze terapeutiche e di sviluppo, enormi capitali e risorse tecniche, che consentono loro di gestire gli impegnativi programmi di sviluppo di farmaci delle aziende farmaceutiche e biofarmaceutiche.
Segmenti chiave del mercato
Il mercato dell\'outsourcing degli affari normativi nel settore sanitario dell\'area APAC ha registrato sono stati segmentati in base al tipo di servizio, all\'utente finale e al Paese. Sulla base del tipo di servizio, il mercato dell\'outsourcing degli affari regolatori sanitari dell\'area APAC è segmentato in servizi medici e di regolamentazione. scrittura scientifica, farmacovigilanza, servizi di gestione dei dati, servizi di gestione del ciclo di vita, eCTD e e-Submissions, sviluppo di strategie scientifiche e normative, servizi di produzione e controlli chimici (CMC), etichettatura normativa e servizi di grafica normativa. Il medico & Il segmento della scrittura scientifica ha dominato il mercato nel 2020 e si prevede che il segmento della farmacovigilanza sarà quello in più rapida crescita durante il periodo di previsione. In base all’utente finale, il mercato è segmentato in aziende farmaceutiche, aziende di biotecnologia e aziende di dispositivi medici. Il segmento delle aziende farmaceutiche ha dominato il mercato nel 2020 e si prevede che sarà quello in più rapida crescita durante il periodo di previsione. Allo stesso modo, le società di dispositivi medici segmentate sono classificate in materiali per dispositivi medici e amp; biomateriali, dispositivi medici, biomarcatori e diagnostica in vitro (IVD), software per dispositivi medici (SaMD), elettromeccanica di dispositivi medici, dispositivi medici basati su sostanze e dispositivi medici di prodotti combinati.
< span>Principali fonti e aziende elencate
Alcune principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sull\'assistenza sanitaria mercato dell’outsourcing degli affari normativi nell’APAC sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra gli altri. Le principali aziende elencate nel rapporto sono Arriello Ireland Ltd., Azierta Contract Science Support Consulting, IQVIA Inc., PAREXEL INTERNATIONAL CORPORATION, PHARMALEX GMBH, ProductLife Group, ProPharma Group e Voisin Consulting Life Sciences (VCLS) sono tra le altre.
Motivi per acquistare il rapporto
- Comprendere il panorama del mercato dell\'outsourcing degli affari normativi nel settore sanitario dell\'area APAC e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte rendimento
- Stai al passo con la concorrenza comprendendo il panorama competitivo in continua evoluzione per il mercato dell\'outsourcing degli affari normativi nel settore sanitario dell\'area APAC
- Pianifica in modo efficiente operazioni di fusione e acquisizione e accordi di partnership nella regolamentazione sanitaria dell\'area APAC mercato dell\'outsourcing degli affari identificando i segmenti di mercato con le vendite probabili più promettenti
- Aiuta a prendere decisioni aziendali consapevoli dall\'analisi perspicace e completa delle prestazioni di mercato dei vari segmenti dell\'outsourcing degli affari normativi sanitari dell\'area APAC mercato
- Ottieni previsioni sui ricavi del mercato per vari segmenti dal 2021 al 2028 nella regione APAC.
Segmentazione del mercato dell\'outsourcing per gli affari normativi nel settore sanitario dell\'area APAC
Area sanitaria del settore sanitario Mercato dell\'outsourcing degli affari normativi: pertipo di servizio
- medico e ; Scrittura scientifica
- Farmacovigilanza
- Servizi di gestione dei dati
- Ciclo di vita Servizi di gestione
- eCTD e presentazioni elettroniche
- Sviluppo di strategie scientifiche e normative
- Servizi di produzione e controlli chimici (CMC)
- Etichettatura normativa
- Servizi di grafica normativa
Mercato dell\'outsourcing degli affari normativi nel settore sanitario dell\'area APAC - per utente finale
- Aziende farmaceutiche
- Aziende di biotecnologie
- Aziende di dispositivi medici
- Materiali e amp; Biomateriali
- Biomarcatori per dispositivi medici e diagnostica in vitro (IVD)
- Software per dispositivi medici (SaMD)
- Elettromeccanica di dispositivi medici
- Dispositivo medico basato su sostanze
- Dispositivo medico di prodotto combinato
Mercato dell\'outsourcing degli affari normativi nel settore sanitario dell\'area APAC - Per paese
- Giappone
- Cina
- India
- Corea del Sud
- Australia
- Resto dell\'APAC
Mercato dell\'outsourcing degli affari normativi nel settore sanitario dell\'area APAC -Profili aziendali
- Arriello Ireland Ltd.
- Azierta Contract Science Support Consulting
- IQVIA Inc.
- PAREXEL INTERNATIONAL CORPORATION
- PHARMALEX GMBH
- Gruppo ProductLife
- Gruppo ProPharma
- Voisin Consulting Life Sciences (VCLS)
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Healthcare Regulatory Affairs Outsourcing Market – By Service Type
1.3.2 APAC Healthcare Regulatory Affairs Outsourcing Market – By End User
1.3.3 APAC Healthcare Regulatory Affairs Outsourcing Market – By Country
2. APAC Healthcare Regulatory Affairs Outsourcing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Healthcare Regulatory Affairs Outsourcing Market – Market Landscape
4.1 Overview
4.1.1 Asia Pacific– PEST Analysis
4.2 Expert Opinions
5. APAC Healthcare Regulatory Affairs Outsourcing Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Regulatory Pressure on Healthcare Companies
5.1.2 Escalating Demand for Speedy Approval of New Products
5.2 Market Restraints
5.2.1 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Advancements in Specialty Therapies, Orphan Drugs, and Personalized Medicines
5.4 Future Trends
5.4.1 Surging Market Consolidation Activities
5.5 Impact Analysis
6. Healthcare Regulatory Affairs Outsourcing Market – APAC Analysis
6.1 APAC Healthcare Regulatory Affairs Outsourcing Market Revenue Forecast and Analysis
7. Healthcare Regulatory Affairs Outsourcing Market Analysis – By Service Type
7.1 Overview
7.2 Healthcare Regulatory Affairs Outsourcing Market, by Service Type (2021 and 2028)
7.3 Regulatory and Scientific Strategy Development
7.3.1 Overview
7.3.2 Regulatory and Scientific Strategy Development: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Medical and Scientific Writing
7.4.1 Overview
7.4.2 Medical and Scientific Writing: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.5 eCTD and E-Submissions
7.5.1 Overview
7.5.2 eCTD and E-Submissions: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Data Management Services
7.6.1 Overview
7.6.2 Data Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Life Cycle Management Services
7.7.1 Overview
7.7.2 Life Cycle Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Pharmacovigilance
7.8.1 Overview
7.8.2 Pharmacovigilance : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Chemistry Manufacturing and Controls (CMC) Services
7.9.1 Overview
7.9.2 Chemistry Manufacturing & Controls ((CMC) Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Regulatory Labelling
7.10.1 Overview
7.10.2 Regulatory Labelling : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.11 Regulatory Artwork Services
7.11.1 Overview
7.11.2 Regulatory Artwork Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8. APAC Healthcare Regulatory Affairs Outsourcing Market Analysis – By End User
8.1 Overview
8.2 Healthcare Regulatory Affairs Outsourcing Market, by End-User (2020 and 2028)
8.3 Pharmaceutical Companies
8.3.1 Overview
8.3.2 Pharmaceutical Companies: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Biotechnology Companies
8.4.1 Overview
8.4.2 Biotechnology Companies : Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Medical Device Companies
8.5.1 Overview
8.5.2 Medical Device Companies: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.5.2.1 Medical Device Software (SaMD) Market
8.5.2.1.1 Overview
8.5.2.1.2 Medical Device Software (SaMD) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.2 Medical Device Materials & Biomaterials Market
8.5.2.2.1 Overview
8.5.2.2.2 Medical Device Materials & Biomaterials Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.3 Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market
8.5.2.3.1 Overview
8.5.2.3.2 Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.4 Medical Device Electro mechanics Market
8.5.2.4.1 Overview
8.5.2.4.2 Medical Device Electro mechanics Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.5 Medical Device Substance Based Market
8.5.2.5.1 Overview
8.5.2.5.2 Medical Device Substance Based Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.6 Medical Device of Combination Product (DDC) Market
8.5.2.6.1 Overview
8.5.2.6.2 Medical Device of Combination Product (DDC) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
9. APAC Healthcare Regulatory Affairs Outsourcing Market – Country Analysis
9.1 Overview
9.1.1 Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Country, 2021 & 2028 (%)
9.1.1.1 China: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 China: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 China: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.1.3 China: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.1.3.1 China: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.2 Japan: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 Japan: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 Japan: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.2.3 Japan: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.2.3.1 Japan: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.3 India: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 India: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 India: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.3.3 India: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.3.3.1 India: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.4 Australia: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 Australia: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 Australia: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.4.3 Australia: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.4.3.1 Australia: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.5 South Korea: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.1 South Korea: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2 South Korea: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.5.3 South Korea: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.5.3.1 South Korea: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.6 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.1 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.6.3 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.6.3.1 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on APAC Healthcare Regulatory Affairs Outsourcing Market
10.1 Overview
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 ProPharma Group
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Arriello Ireland Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 PAREXEL INTERNATIONAL CORPORATION
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 IQVIA Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 PHARMALEX GMBH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 ProductLife Group
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Voisin Consulting Life Sciences (VCLS)
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Azierta Contract Science Support Consulting
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. APAC Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecast to 2028 (US$ Million)
Table 2. China: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 3. China: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 4. China: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Healthcare Regulatory Affairs Outsourcing Market, By Service Type– Revenue and Forecast to 2028 (USD Million)
Table 6. Japan: Healthcare Regulatory Affairs Outsourcing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies – Revenue and Forecast to 2028 (USD Million)
Table 8. India: Healthcare Regulatory Affairs Outsourcing Market, By Service Type– Revenue and Forecast to 2028 (USD Million)
Table 9. India: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 10. India: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 11. Australia: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Australia: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Australia: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 14. South Korea: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 15. South Korea: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 16. South Korea: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 20. Organic Developments in the Healthcare Regulatory Affairs Outsourcing Market
Table 21. Inorganic Developments in the Healthcare Regulatory Affairs Outsourcing Market
Table 22. Glossary of Terms, APAC Healthcare Regulatory Affairs Outsourcing Market
LIST OF FIGURES
Figure 1. APAC Healthcare Regulatory Affairs Outsourcing Market Segmentation
Figure 2. APAC Healthcare Regulatory Affairs Outsourcing Market Segmentation, By Country
Figure 3. APAC Healthcare Regulatory Affairs Outsourcing Market Overview
Figure 4. Medical & Scientific Writing Segment Held the Largest Share of the Service Type Segment in APAC Healthcare Regulatory Affairs Outsourcing Market
Figure 5. India to Show Significant Growth During Forecast Period
Figure 6. Asia pacific PEST Analysis
Figure 7. APAC Healthcare Regulatory Affairs Outsourcing Market Impact Analysis of Driver and Restraints
Figure 8. APAC Healthcare Regulatory Affairs Outsourcing Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. APAC Healthcare Regulatory Affairs Outsourcing Market Revenue Share, by Service Type (2020 and 2028)
Figure 10. APAC Regulatory and Scientific Strategy Development: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. APAC Medical and Scientific Writing: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. APAC eCTD and E-Submissions: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. APAC Data Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. APAC Life Cycle Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. APAC Pharmacovigilance : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. APAC Chemistry Manufacturing & Controls ((CMC) Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. APAC Regulatory Labelling: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. APAC Regulatory Artwork Services : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. APAC Healthcare Regulatory Affairs Outsourcing Market Revenue Share, by End-User (2020 and 2028)
Figure 20. APAC Pharmaceutical Companies : Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. APAC Biotechnology Companies: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. APAC Medical Device Companies: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. APAC Medical Device Software (SaMD) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. APAC Medical Device Materials & Biomaterials Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. APAC Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. APAC Medical Device Electro mechanics Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. APAC Medical Device Substance Based Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. APAC Medical Device of Combination Product (DDC) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Key Country – Revenue (2021) (USD Million)
Figure 30. Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Country, 2021 & 2028 (%)
Figure 31. China: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Japan: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. India: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Australia: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. South Korea: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Arriello Ireland Ltd.
- Azierta Contract Science Support Consulting
- IQVIA Inc.
- PAREXEL INTERNATIONAL CORPORATION
- PHARMALEX GMBH
- ProductLife Group
- ProPharma Group
- Voisin Consulting Life Sciences (VCLS)
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the APAC Healthcare Regulatory Affairs Outsourcing market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the APAC Healthcare Regulatory Affairs Outsourcing market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the Healthcare Regulatory Affairs Outsourcing market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution